Radioimmunotherapy Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Non Hodgkin Lymphoma (NHL)
1.2.3 Follicular Lymphoma
1.2.4 Solid Tumors
1.2.5 Breast Cancer
1.2.6 Ovarian Cancer
1.2.7 Osteosarcoma
1.2.8 Neuroblastoma
1.2.9 Prostate Cancer
1.3 Market by Application
1.3.1 Global Radioimmunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Tumor Antigens
1.3.3 Radionuclides
1.3.4 Antibodies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Radioimmunotherapy Market Perspective (2017-2028)
2.2 Radioimmunotherapy Growth Trends by Region
2.2.1 Radioimmunotherapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radioimmunotherapy Historic Market Size by Region (2017-2022)
2.2.3 Radioimmunotherapy Forecasted Market Size by Region (2023-2028)
2.3 Radioimmunotherapy Market Dynamics
2.3.1 Radioimmunotherapy Industry Trends
2.3.2 Radioimmunotherapy Market Drivers
2.3.3 Radioimmunotherapy Market Challenges
2.3.4 Radioimmunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radioimmunotherapy Players by Revenue
3.1.1 Global Top Radioimmunotherapy Players by Revenue (2017-2022)
3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2017-2022)
3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radioimmunotherapy Revenue
3.4 Global Radioimmunotherapy Market Concentration Ratio
3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2021
3.5 Radioimmunotherapy Key Players Head office and Area Served
3.6 Key Players Radioimmunotherapy Product Solution and Service
3.7 Date of Enter into Radioimmunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radioimmunotherapy Breakdown Data by Type
4.1 Global Radioimmunotherapy Historic Market Size by Type (2017-2022)
4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2023-2028)
5 Radioimmunotherapy Breakdown Data by Application
5.1 Global Radioimmunotherapy Historic Market Size by Application (2017-2022)
5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Radioimmunotherapy Market Size (2017-2028)
6.2 North America Radioimmunotherapy Market Size by Type
6.2.1 North America Radioimmunotherapy Market Size by Type (2017-2022)
6.2.2 North America Radioimmunotherapy Market Size by Type (2023-2028)
6.2.3 North America Radioimmunotherapy Market Share by Type (2017-2028)
6.3 North America Radioimmunotherapy Market Size by Application
6.3.1 North America Radioimmunotherapy Market Size by Application (2017-2022)
6.3.2 North America Radioimmunotherapy Market Size by Application (2023-2028)
6.3.3 North America Radioimmunotherapy Market Share by Application (2017-2028)
6.4 North America Radioimmunotherapy Market Size by Country
6.4.1 North America Radioimmunotherapy Market Size by Country (2017-2022)
6.4.2 North America Radioimmunotherapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Radioimmunotherapy Market Size (2017-2028)
7.2 Europe Radioimmunotherapy Market Size by Type
7.2.1 Europe Radioimmunotherapy Market Size by Type (2017-2022)
7.2.2 Europe Radioimmunotherapy Market Size by Type (2023-2028)
7.2.3 Europe Radioimmunotherapy Market Share by Type (2017-2028)
7.3 Europe Radioimmunotherapy Market Size by Application
7.3.1 Europe Radioimmunotherapy Market Size by Application (2017-2022)
7.3.2 Europe Radioimmunotherapy Market Size by Application (2023-2028)
7.3.3 Europe Radioimmunotherapy Market Share by Application (2017-2028)
7.4 Europe Radioimmunotherapy Market Size by Country
7.4.1 Europe Radioimmunotherapy Market Size by Country (2017-2022)
7.4.2 Europe Radioimmunotherapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radioimmunotherapy Market Size (2017-2028)
8.2 Asia-Pacific Radioimmunotherapy Market Size by Type
8.2.1 Asia-Pacific Radioimmunotherapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Radioimmunotherapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Radioimmunotherapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Radioimmunotherapy Market Size by Application
8.3.1 Asia-Pacific Radioimmunotherapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Radioimmunotherapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Radioimmunotherapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Radioimmunotherapy Market Size by Region
8.4.1 Asia-Pacific Radioimmunotherapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Radioimmunotherapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Radioimmunotherapy Market Size (2017-2028)
9.2 Latin America Radioimmunotherapy Market Size by Type
9.2.1 Latin America Radioimmunotherapy Market Size by Type (2017-2022)
9.2.2 Latin America Radioimmunotherapy Market Size by Type (2023-2028)
9.2.3 Latin America Radioimmunotherapy Market Share by Type (2017-2028)
9.3 Latin America Radioimmunotherapy Market Size by Application
9.3.1 Latin America Radioimmunotherapy Market Size by Application (2017-2022)
9.3.2 Latin America Radioimmunotherapy Market Size by Application (2023-2028)
9.3.3 Latin America Radioimmunotherapy Market Share by Application (2017-2028)
9.4 Latin America Radioimmunotherapy Market Size by Country
9.4.1 Latin America Radioimmunotherapy Market Size by Country (2017-2022)
9.4.2 Latin America Radioimmunotherapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radioimmunotherapy Market Size (2017-2028)
10.2 Middle East & Africa Radioimmunotherapy Market Size by Type
10.2.1 Middle East & Africa Radioimmunotherapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Radioimmunotherapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Radioimmunotherapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Radioimmunotherapy Market Size by Application
10.3.1 Middle East & Africa Radioimmunotherapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Radioimmunotherapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Radioimmunotherapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Radioimmunotherapy Market Size by Country
10.4.1 Middle East & Africa Radioimmunotherapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Radioimmunotherapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer Healthcare Pharmaceuticals
11.1.1 Bayer Healthcare Pharmaceuticals Company Details
11.1.2 Bayer Healthcare Pharmaceuticals Business Overview
11.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction
11.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
11.1.5 Bayer Healthcare Pharmaceuticals Recent Developments
11.2 BioSynthema
11.2.1 BioSynthema Company Details
11.2.2 BioSynthema Business Overview
11.2.3 BioSynthema Radioimmunotherapy Introduction
11.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2017-2022)
11.2.5 BioSynthema Recent Developments
11.3 Clarity Pharmaceuticals
11.3.1 Clarity Pharmaceuticals Company Details
11.3.2 Clarity Pharmaceuticals Business Overview
11.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction
11.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
11.3.5 Clarity Pharmaceuticals Recent Developments
11.4 Curasight
11.4.1 Curasight Company Details
11.4.2 Curasight Business Overview
11.4.3 Curasight Radioimmunotherapy Introduction
11.4.4 Curasight Revenue in Radioimmunotherapy Business (2017-2022)
11.4.5 Curasight Recent Developments
11.5 Endocyte
11.5.1 Endocyte Company Details
11.5.2 Endocyte Business Overview
11.5.3 Endocyte Radioimmunotherapy Introduction
11.5.4 Endocyte Revenue in Radioimmunotherapy Business (2017-2022)
11.5.5 Endocyte Recent Developments
11.6 Immunomedics
11.6.1 Immunomedics Company Details
11.6.2 Immunomedics Business Overview
11.6.3 Immunomedics Radioimmunotherapy Introduction
11.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2017-2022)
11.6.5 Immunomedics Recent Developments
11.7 Molecular Insight Pharmaceuticals
11.7.1 Molecular Insight Pharmaceuticals Company Details
11.7.2 Molecular Insight Pharmaceuticals Business Overview
11.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction
11.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
11.7.5 Molecular Insight Pharmaceuticals Recent Developments
11.8 Nordic Nanovector
11.8.1 Nordic Nanovector Company Details
11.8.2 Nordic Nanovector Business Overview
11.8.3 Nordic Nanovector Radioimmunotherapy Introduction
11.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022)
11.8.5 Nordic Nanovector Recent Developments
11.9 PDL Biopharma
11.9.1 PDL Biopharma Company Details
11.9.2 PDL Biopharma Business Overview
11.9.3 PDL Biopharma Radioimmunotherapy Introduction
11.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022)
11.9.5 PDL Biopharma Recent Developments
11.10 Philogen
11.10.1 Philogen Company Details
11.10.2 Philogen Business Overview
11.10.3 Philogen Radioimmunotherapy Introduction
11.10.4 Philogen Revenue in Radioimmunotherapy Business (2017-2022)
11.10.5 Philogen Recent Developments
11.11 RadioMedix
11.11.1 RadioMedix Company Details
11.11.2 RadioMedix Business Overview
11.11.3 RadioMedix Radioimmunotherapy Introduction
11.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2017-2022)
11.11.5 RadioMedix Recent Developments
11.12 Stella Pharma
11.12.1 Stella Pharma Company Details
11.12.2 Stella Pharma Business Overview
11.12.3 Stella Pharma Radioimmunotherapy Introduction
11.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022)
11.12.5 Stella Pharma Recent Developments
11.13 Telix Pharmaceuticals
11.13.1 Telix Pharmaceuticals Company Details
11.13.2 Telix Pharmaceuticals Business Overview
11.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction
11.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
11.13.5 Telix Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Non Hodgkin Lymphoma (NHL)
Table 3. Key Players of Follicular Lymphoma
Table 4. Key Players of Solid Tumors
Table 5. Key Players of Breast Cancer
Table 6. Key Players of Ovarian Cancer
Table 7. Key Players of Osteosarcoma
Table 8. Key Players of Neuroblastoma
Table 9. Key Players of Prostate Cancer
Table 10. Global Radioimmunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 11. Global Radioimmunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Radioimmunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Radioimmunotherapy Market Share by Region (2017-2022)
Table 14. Global Radioimmunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Radioimmunotherapy Market Share by Region (2023-2028)
Table 16. Radioimmunotherapy Market Trends
Table 17. Radioimmunotherapy Market Drivers
Table 18. Radioimmunotherapy Market Challenges
Table 19. Radioimmunotherapy Market Restraints
Table 20. Global Radioimmunotherapy Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Radioimmunotherapy Revenue Share by Players (2017-2022)
Table 22. Global Top Radioimmunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2021)
Table 23. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Radioimmunotherapy Product Solution and Service
Table 27. Date of Enter into Radioimmunotherapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Radioimmunotherapy Revenue Market Share by Type (2017-2022)
Table 31. Global Radioimmunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Radioimmunotherapy Revenue Market Share by Type (2023-2028)
Table 33. Global Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Radioimmunotherapy Revenue Share by Application (2017-2022)
Table 35. Global Radioimmunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Radioimmunotherapy Revenue Share by Application (2023-2028)
Table 37. North America Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. North America Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. North America Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. North America Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. North America Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. North America Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Europe Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Europe Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Europe Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Europe Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Europe Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 48. Europe Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 49. Asia Pacific Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Asia Pacific Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Asia Pacific Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Asia Pacific Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Asia Pacific Radioimmunotherapy Market Size by Region (2017-2022) & (US$ Million)
Table 54. Asia Pacific Radioimmunotherapy Market Size by Region (2023-2028) & (US$ Million)
Table 55. Latin America Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Latin America Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Latin America Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Latin America Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Latin America Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Latin America Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
Table 63. Middle East and Africa Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
Table 64. Middle East and Africa Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
Table 65. Middle East and Africa Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
Table 66. Middle East and Africa Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
Table 67. Bayer Healthcare Pharmaceuticals Company Details
Table 68. Bayer Healthcare Pharmaceuticals Business Overview
Table 69. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product
Table 70. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 71. Bayer Healthcare Pharmaceuticals Recent Developments
Table 72. BioSynthema Company Details
Table 73. BioSynthema Business Overview
Table 74. BioSynthema Radioimmunotherapy Product
Table 75. BioSynthema Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 76. BioSynthema Recent Developments
Table 77. Clarity Pharmaceuticals Company Details
Table 78. Clarity Pharmaceuticals Business Overview
Table 79. Clarity Pharmaceuticals Radioimmunotherapy Product
Table 80. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 81. Clarity Pharmaceuticals Recent Developments
Table 82. Curasight Company Details
Table 83. Curasight Business Overview
Table 84. Curasight Radioimmunotherapy Product
Table 85. Curasight Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 86. Curasight Recent Developments
Table 87. Endocyte Company Details
Table 88. Endocyte Business Overview
Table 89. Endocyte Radioimmunotherapy Product
Table 90. Endocyte Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 91. Endocyte Recent Developments
Table 92. Immunomedics Company Details
Table 93. Immunomedics Business Overview
Table 94. Immunomedics Radioimmunotherapy Product
Table 95. Immunomedics Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 96. Immunomedics Recent Developments
Table 97. Molecular Insight Pharmaceuticals Company Details
Table 98. Molecular Insight Pharmaceuticals Business Overview
Table 99. Molecular Insight Pharmaceuticals Radioimmunotherapy Product
Table 100. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 101. Molecular Insight Pharmaceuticals Recent Developments
Table 102. Nordic Nanovector Company Details
Table 103. Nordic Nanovector Business Overview
Table 104. Nordic Nanovector Radioimmunotherapy Product
Table 105. Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 106. Nordic Nanovector Recent Developments
Table 107. PDL Biopharma Company Details
Table 108. PDL Biopharma Business Overview
Table 109. PDL Biopharma Radioimmunotherapy Product
Table 110. PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 111. PDL Biopharma Recent Developments
Table 112. Philogen Company Details
Table 113. Philogen Business Overview
Table 114. Philogen Radioimmunotherapy Product
Table 115. Philogen Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 116. Philogen Recent Developments
Table 117. RadioMedix Company Details
Table 118. RadioMedix Business Overview
Table 119. RadioMedix Radioimmunotherapy Product
Table 120. RadioMedix Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 121. RadioMedix Recent Developments
Table 122. Stella Pharma Company Details
Table 123. Stella Pharma Business Overview
Table 124. Stella Pharma Radioimmunotherapy Product
Table 125. Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 126. Stella Pharma Recent Developments
Table 127. Telix Pharmaceuticals Company Details
Table 128. Telix Pharmaceuticals Business Overview
Table 129. Telix Pharmaceuticals Radioimmunotherapy Product
Table 130. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
Table 131. Telix Pharmaceuticals Recent Developments
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioimmunotherapy Market Share by Type: 2021 VS 2028
Figure 2. Non Hodgkin Lymphoma (NHL) Features
Figure 3. Follicular Lymphoma Features
Figure 4. Solid Tumors Features
Figure 5. Breast Cancer Features
Figure 6. Ovarian Cancer Features
Figure 7. Osteosarcoma Features
Figure 8. Neuroblastoma Features
Figure 9. Prostate Cancer Features
Figure 10. Global Radioimmunotherapy Market Share by Application: 2021 VS 2028
Figure 11. Tumor Antigens Case Studies
Figure 12. Radionuclides Case Studies
Figure 13. Antibodies Case Studies
Figure 14. Radioimmunotherapy Report Years Considered
Figure 15. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 16. Global Radioimmunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Radioimmunotherapy Market Share by Region: 2021 VS 2028
Figure 18. Global Radioimmunotherapy Market Share by Players in 2021
Figure 19. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2021)
Figure 20. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2021
Figure 21. North America Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. North America Radioimmunotherapy Market Size Market Share by Type (2017-2028)
Figure 23. North America Radioimmunotherapy Market Size Market Share by Application (2017-2028)
Figure 24. North America Radioimmunotherapy Market Size Share by Country (2017-2028)
Figure 25. United States Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Canada Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Europe Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 28. Europe Radioimmunotherapy Market Size Market Share by Type (2017-2028)
Figure 29. Europe Radioimmunotherapy Market Size Market Share by Application (2017-2028)
Figure 30. Europe Radioimmunotherapy Market Size Share by Country (2017-2028)
Figure 31. Germany Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. France Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. U.K. Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Italy Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Russia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Nordic Countries Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 38. Asia Pacific Radioimmunotherapy Market Size Market Share by Type (2017-2028)
Figure 39. Asia Pacific Radioimmunotherapy Market Size Market Share by Application (2017-2028)
Figure 40. Asia Pacific Radioimmunotherapy Market Size Share by Region (2017-2028)
Figure 41. China Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Japan Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. South Korea Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. India Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Australia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 47. Latin America Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Latin America Radioimmunotherapy Market Size Market Share by Type (2017-2028)
Figure 49. Latin America Radioimmunotherapy Market Size Market Share by Application (2017-2028)
Figure 50. Latin America Radioimmunotherapy Market Size Share by Country (2017-2028)
Figure 51. Mexico Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Brazil Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Middle East & Africa Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
Figure 54. Middle East and Africa Radioimmunotherapy Market Size Market Share by Type (2017-2028)
Figure 55. Middle East and Africa Radioimmunotherapy Market Size Market Share by Application (2017-2028)
Figure 56. Middle East and Africa Radioimmunotherapy Market Size Share by Country (2017-2028)
Figure 57. Turkey Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. UAE Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 60. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 61. BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 62. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 63. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 64. Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 65. Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 66. Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 67. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 68. PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 69. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 70. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 71. Stella Pharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 72. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Industry Market Size
